The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation
Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that doe...
Saved in:
Main Authors: | Letian Xu, Yuting Zhou, Rui Ma, Xinqin Guo, Hao Chen, Lei Fan, Xiaoming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2024-04-01
|
Series: | Acta Materia Medica |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01) -
Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
by: Songjie Chen, et al.
Published: (2017-04-01) -
Ophthalmological Manifestations in Acute Lymphoblastic Leukemia
by: Mateo, Javier, et al.
Published: (2011) -
Cross-Sectional Study: Associations of A20 and Cezanne with Leukocyte Accumulation in B-Cell Acute Lymphoblastic Leukemia
by: Le Thuy Ha, et al.
Published: (2025-06-01) -
Sulforaphane attenuates aldose reductase-mediated platelet dysfunction in high glucose-stimulated human platelets via downregulation of the Src/ROS/p53 signaling pathway
by: Xiaoyan Bi, et al.
Published: (2025-08-01)